These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 7889283

  • 1. Effect of type A and B monoamine oxidase selective inhibition by Ro 41-1049 and Ro 19-6327 on dopamine outflow in rat kidney slices.
    Pestana M, Soares-da-Silva P.
    Br J Pharmacol; 1994 Dec; 113(4):1269-74. PubMed ID: 7889283
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of MAO-A and MAO-B selective inhibitors Ro 41-1049 and Ro 19-6327 on the deamination of newly formed dopamine in the rat kidney.
    Fernandes MH, Soares-da-Silva P.
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1309-13. PubMed ID: 2124622
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The renal handling of dopamine originating from L-dopa and gamma-glutamyl-L-dopa.
    Pestana M, Soares-da-Silva P.
    Br J Pharmacol; 1994 Jun; 112(2):417-22. PubMed ID: 8075859
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vivo effects of the monoamine oxidase inhibitors Ro 41-1049 and Ro 19-6327 on the production and fate of renal dopamine.
    Vieira-Coelho MA, Fernandes MH, Soares-da-Silva P.
    J Neural Transm Suppl; 1994 Jun; 41():365-70. PubMed ID: 7931252
    [Abstract] [Full Text] [Related]

  • 8. The activity of MAO A and B in rat renal cells and tubules.
    Guimarães JT, Soares-da-Silva P.
    Life Sci; 1998 Jun; 62(8):727-37. PubMed ID: 9489509
    [Abstract] [Full Text] [Related]

  • 9. Effect of selective and reversible MAO inhibitors on dopamine outflow in rat striatum: a microdialysis study.
    Colzi A, d'Agostini F, Kettler R, Borroni E, Da Prada M.
    J Neural Transm Suppl; 1990 Jun; 32():79-84. PubMed ID: 2089114
    [Abstract] [Full Text] [Related]

  • 10. In vivo comparison of the effects of inhibition of MAO-A versus MAO-B on striatal L-DOPA and dopamine metabolism.
    Brannan T, Prikhojan A, Martínez-Tica J, Yahr MD.
    J Neural Transm Park Dis Dement Sect; 1995 Jun; 10(2-3):79-89. PubMed ID: 9620056
    [Abstract] [Full Text] [Related]

  • 11. Sodium-dependence and ouabain-sensitivity of the synthesis of dopamine in renal tissues of the rat.
    Soares-da-Silva P, Fernandes MH.
    Br J Pharmacol; 1992 Apr; 105(4):811-6. PubMed ID: 1504714
    [Abstract] [Full Text] [Related]

  • 12. L-3,4-dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors.
    Wachtel SR, Abercrombie ED.
    J Neurochem; 1994 Jul; 63(1):108-17. PubMed ID: 8207420
    [Abstract] [Full Text] [Related]

  • 13. Effect of a selective MAO-A inhibitor (Ro 41-1049) on striatal L-dopa and dopamine metabolism: an in vivo study.
    Brannan T, Prikhojan A, Yahr MD.
    J Neural Transm Park Dis Dement Sect; 1994 Jul; 8(1-2):99-105. PubMed ID: 7893380
    [Abstract] [Full Text] [Related]

  • 14. Outflow of dopamine and noradrenaline originating from L-dopa and L-threo-DOPS in rat renal tissues.
    Pestana M, Soares-Da-Silva P.
    Gen Pharmacol; 1994 Sep; 25(5):879-85. PubMed ID: 7835631
    [Abstract] [Full Text] [Related]

  • 15. Role of type A and B monoamine oxidase on the formation of 3,4-dihydroxyphenylacetic acid (DOPAC) in tissues from the brain of the rat.
    Garrett MC, Soares-da-Silva P.
    Neuropharmacology; 1990 Oct; 29(10):875-9. PubMed ID: 2123970
    [Abstract] [Full Text] [Related]

  • 16. Microdialysis with radiometric monitoring of L-[β-11C]DOPA to assess dopaminergic metabolism: effect of inhibitors of L-amino acid decarboxylase, monoamine oxidase, and catechol-O-methyltransferase on rat striatal dialysate.
    Okada M, Nakao R, Hosoi R, Zhang MR, Fukumura T, Suzuki K, Inoue O.
    J Cereb Blood Flow Metab; 2011 Jan; 31(1):124-31. PubMed ID: 20407462
    [Abstract] [Full Text] [Related]

  • 17. Role of monoamine oxidase and catechol-O-methyltransferase in the metabolism of renal dopamine.
    Fernandes MH, Soares-da-Silva P.
    J Neural Transm Suppl; 1994 Jan; 41():101-5. PubMed ID: 7931214
    [Abstract] [Full Text] [Related]

  • 18. Effect of high single doses of levodopa and carbidopa on brain dopamine and its metabolites: modulation by selective inhibitors of monoamine oxidase and/or catechol-O-methyltransferase in the male rat.
    Männistö PT, Tuomainen P.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):412-8. PubMed ID: 1766471
    [Abstract] [Full Text] [Related]

  • 19. Comparison of short and long-lasting effects of pargyline on cerebral dopamine metabolism.
    Waldmeier PC, Maître L.
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Aug; 294(2):133-40. PubMed ID: 1012333
    [Abstract] [Full Text] [Related]

  • 20. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys.
    Di Monte DA, DeLanney LE, Irwin I, Royland JE, Chan P, Jakowec MW, Langston JW.
    Brain Res; 1996 Oct 28; 738(1):53-9. PubMed ID: 8949927
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.